Arca Biopharma | ABIO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 13.99B 1.95B 2026-06
Arca Biopharma USD 268.47M 218.95M 2026-06
Biogen USD 1.28B 2.1B 2026-06
Brainstorm Cell Therapeutics USD 22K 7K 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Capricor Therapeutics USD 20.94M 84.49M 2026-06
Cipla INR 10.18B 2.22B 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
CSL USD 2.16B 633M 2025-06
Cytokinetics USD 255.27M 125.43M 2026-06
Daiichi Sankyo JPY 449.81B 92.35B 2026-03
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Laboratory Of America USD 141.8M 839.3M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Otsuka Holdings JPY 534.64B 123.53B 2025-12
Pfizer USD 976M 727M 2026-06
United Therapeutics USD 1.8B 523.5M 2026-06